Heart Rate Regularization in Atrial Fibrilation and Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 334 participants.

Also called NCT05029570

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 334 participants (planned count) (from the registry)
Sponsor
Daniel Rodríguez Muñoz (from the registry)
Registry
  • NCT NCT05029570
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05029570. Randomized; single masking; primary purpose treatment. Start 2022-04-29 (actual); primary completion 2030-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Heart Rate Regularization in Atrial Fibrilation and Heart Failure
Acronym
PACE-FIB
Condition
Heart Failure
Intervention (Device)
Conduction System Pacing (pacemaker implantation)
Lead sponsor
Daniel Rodríguez Muñoz (class: other)
Collaborator
Sociedad Castellana de Cardiologia (class: other)

Record details

Record id
cardio:ct-nct05029570
Content hash
6ae945d450d78ad23c0c0c8995e29889e0543a829a609f87ec509368e8f07a4c